Login
$VRDN
$23.34 +$0.97 (4.34%) Close

$VRDN 4 SEC Filings

Filed On Filing
20 Aug 2026 Form 4: Tousignant Jennifer, Chief Legal Officer

Sold 14,212 shares ($348K) · Received 10,000 shares by exercise or conversion ($144K)

18 Aug 2026 Form 4: Tripuraneni Radhika, Chief Medical Officer

Received 40,000 shares by exercise or conversion ($528K)

02 Jul 2026 Form 4: Cain Christopher W., Director

Granted 32,341 Stock Option (Right to Buy)

02 Jul 2026 Form 4: Ajer Jeffrey Robert, Director

Granted 32,341 Stock Option (Right to Buy)

02 Jul 2026 Form 4: Moses Jennifer K., Director

Granted 32,341 Stock Option (Right to Buy)

02 Jul 2026 Form 4: Gheuens Sarah, Director

Granted 32,341 Stock Option (Right to Buy)

02 Jul 2026 Form 4: Kiselak Tomas, Director

Granted 32,341 Stock Option (Right to Buy)

02 Jul 2026 Form 4: Morris Arlene, Director

Granted 32,341 Stock Option (Right to Buy)

13 May 2026 Form 4: Fairmount Funds Management Llc, Director and 2 others

Bought 1,176,470 shares ($20M)

04 Mar 2026 Form 4: Tousignant Jennifer, Chief Legal Officer

Granted 119,300 Stock Option (Right to Buy) · Granted 23,850 Restricted Stock Units · Received 5,169 shares by exercise or conversion · 1 more

04 Mar 2026 Form 4: Harmon Seth, Chief Financial Officer

Granted 102,850 Stock Option (Right to Buy) · Granted 20,550 Restricted Stock Units · Received 6,267 shares by exercise or conversion · 1 more

04 Mar 2026 Form 4: Beetham Thomas W., Chief Operating Officer

Granted 176,550 Stock Option (Right to Buy) · Granted 35,300 Restricted Stock Units · Received 9,409 shares by exercise or conversion · 1 more

04 Mar 2026 Form 4: Mahoney Stephen F., President and CEO

Granted 559,600 Stock Option (Right to Buy) · Granted 111,900 Restricted Stock Units · Received 18,357 shares by exercise or conversion · 1 more

04 Mar 2026 Form 4: Tripuraneni Radhika, Chief Medical Officer

Granted 95,800 Stock Option (Right to Buy) · Granted 19,150 Restricted Stock Units

02 Jan 2026 Form 4: Tousignant Jennifer, Chief Legal Officer

Sold 2,272 shares ($70.8K)

27 Oct 2025 Form 4: Fairmount Funds Management Llc, Director and 2 others

Bought 454,545 shares ($10M)

02 Jul 2025 Form 4: Cain Christopher W., Director

Granted 21,000 Stock Option (Right to Buy)

02 Jul 2025 Form 4: Kiselak Tomas, Director

Granted 21,000 Stock Option (Right to Buy)

02 Jul 2025 Form 4: Morris Arlene, Director

Granted 21,000 Stock Option (Right to Buy)

02 Jul 2025 Form 4: Ajer Jeffrey Robert, Director

Granted 21,000 Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support